The funding round will support the rapid development of single use flexible endoscopes and facilitate the company relocation to Wales.
"IQ Endoscopes disruptive technology eliminates the risk of cross contamination which is at the forefront of clinicians’ minds at the moment with the prevalence of COVID-19. Practitioners can’t risk contamination between endoscopy procedures. Creating a disposable endoscope, which is expected to be positioned at a lower cost point than current technology, is an extremely thrilling prospect and the reason why Creo Medical is keen to support the product development to get IQ Scope and platform to market as quickly as possible."
The funding round was backed by the Development Bank of Wales, an angel syndicate, and the Wales Angel Co-investment Fund.
"Menopause can be life-changing for so many. By empowering women to consider body, mind and lifestyle –and giving them the tools to improve their experience – we hope to really change millions of women’s lives for the better."
The funding was secured from Wealth Club and the Development Bank of Wales to support product development and global expansion.
"Our purpose has always been to help people be better with data. This funding is a fantastic recognition of our hard work and shows a strong belief and confidence in our forward mission as a business."
